LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Cartesian Therapeutics and Millions of Other Companies

Sign up for full access to Cartesian Therapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Recent Key Hire Cartesian Therapeutics appointed Dr. Miloš Miljković as Chief Medical Officer, showcasing a strategic move to enhance clinical programs and drive growth in mRNA cell therapy for autoimmune diseases.

FDA Recognition The FDA designation of Rare Pediatric Disease for Descartes-08 highlights Cartesian Therapeutics' innovative approach in addressing autoimmune diseases, creating a unique selling point for potential collaborations and market positioning.

Inducement Award Strategy By granting awards to new employees and emphasizing development in autoimmune disease treatments, Cartesian Therapeutics demonstrates a commitment to attracting top talent, a key advantage for future sales expansion and research initiatives.

Strategic Board Appointment The addition of Kemal Malik to the Board of Directors strengthens Cartesian Therapeutics' strategic decision-making processes, offering opportunities for partnerships and investments based on the board's expertise and industry connections.

Market Outreach through Training Program The hire of Sneha Saggurthi as Training Program Manager suggests a focus on employee skill development and industry knowledge, potentially opening avenues for educational partnerships and outreach to healthcare professionals.

Similar companies to Cartesian Therapeutics

✕

Access Insights for Cartesian Therapeutics and Millions of Other Companies

Sign up for full access to Cartesian Therapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Cartesian Therapeutics Tech Stack

Cartesian Therapeutics uses 8 technology products and services including Fusion Ads, Cloudinary, Akamai, and more. Explore Cartesian Therapeutics's tech stack below.

  • Fusion Ads
    Advertising
  • Cloudinary
    Content Delivery Network
  • Akamai
    Content Delivery Network
  • MySQL
    Database
  • Module Federation
    Miscellaneous
  • RSS
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Astra
    Web Platform Extensions

Media & News

Cartesian Therapeutics's Email Address Formats

Cartesian Therapeutics uses at least 2 format(s):
Cartesian Therapeutics Email FormatsExamplePercentage
First@cartesiantx.comJohn@cartesiantx.com
49%
First.Last@cartesiantx.comJohn.Doe@cartesiantx.com
42%
FLast@cartesiantx.comJDoe@cartesiantx.com
5%
Last@cartesiantx.comDoe@cartesiantx.com
3%
Fir.Last@cartesiantx.comJoh.Doe@cartesiantx.com
1%
FLast@cartesiantherapeutics.comJDoe@cartesiantherapeutics.com
25%
First@cartesiantherapeutics.comJohn@cartesiantherapeutics.com
25%
FLast@cartesiantherapeutics.comJDoe@cartesiantherapeutics.com
25%
First@cartesiantherapeutics.comJohn@cartesiantherapeutics.com
25%

Frequently Asked Questions

Where is Cartesian Therapeutics's headquarters located?

Minus sign iconPlus sign iconCartesian Therapeutics's main headquarters is located at Gaithersburg, MD 20878 US. The company has employees across 2 continents, including North AmericaAsia.

What is Cartesian Therapeutics's stock symbol?

Minus sign iconPlus sign iconCartesian Therapeutics is a publicly traded company; the company's stock symbol is RNAC.

What is Cartesian Therapeutics's official website and social media links?

Minus sign iconPlus sign iconCartesian Therapeutics's official website is cartesiantherapeutics.com and has social profiles on LinkedIn.

How much revenue does Cartesian Therapeutics generate?

Minus sign iconPlus sign icon As of October 2024, Cartesian Therapeutics's annual revenue reached $3.8M.

What is Cartesian Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconCartesian Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cartesian Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2024, Cartesian Therapeutics has approximately 58 employees across 2 continents, including North AmericaAsia. Key team members include Chief Financial Officer: B. D.Chief People Officer: J. K.Chief Medical Officer: M. M.. Explore Cartesian Therapeutics's employee directory with LeadIQ.

What industry does Cartesian Therapeutics belong to?

Minus sign iconPlus sign iconCartesian Therapeutics operates in the Biotechnology Research industry.

What technology does Cartesian Therapeutics use?

Minus sign iconPlus sign iconCartesian Therapeutics's tech stack includes Fusion AdsCloudinaryAkamaiMySQLModule FederationRSSAmazon Web ServicesAstra.

What is Cartesian Therapeutics's email format?

Minus sign iconPlus sign iconCartesian Therapeutics's email format typically follows the pattern of . Find more Cartesian Therapeutics email formats with LeadIQ.

How much funding has Cartesian Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2024, Cartesian Therapeutics has raised $130M in funding. The last funding round occurred on Jul 02, 2024 for $130M.

When was Cartesian Therapeutics founded?

Minus sign iconPlus sign iconCartesian Therapeutics was founded in 2016.
Cartesian Therapeutics

Cartesian Therapeutics

Biotechnology ResearchMaryland, United States51-200 Employees

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com

✕

Access Insights for Cartesian Therapeutics and Millions of Other Companies

Sign up for full access to Cartesian Therapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Gaithersburg, MD 20878 US
Website
cartesiantherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RNAC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $130M

    Cartesian Therapeutics has raised a total of $130M of funding over 3 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $130M.

  • $10M

    Cartesian Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $130M

    Cartesian Therapeutics has raised a total of $130M of funding over 3 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $130M.

  • $10M

    Cartesian Therapeutics's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Cartesian Therapeutics and Millions of Other Companies

Sign up for full access to Cartesian Therapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.